BC
Broadwood Capital Portfolio holdings
AUM
$1.53B
This Quarter Return
+4.2%
1 Year Return
+36.91%
3 Year Return
+67.63%
5 Year Return
+132.65%
10 Year Return
+697.91%
AUM
$544M
AUM Growth
+$544M
(+3.7%)
Cap. Flow
+$0
Cap. Flow
% of AUM
0%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
–
Increased
–
Reduced
–
Closed
–
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 45.26% |
| 2 | Consumer Staples | 43.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Monster Beverage
MNST
$60.9B
| $238M | 43.83% | 4,797,408 | – | – |
|
2
STAAR Surgical
STAA
$1.36B
| $117M | 21.56% | 10,855,179 | – | – |
|
3
Lineage Cell Therapeutics
LCTX
$267M
| $85.4M | 15.71% | 27,119,254 | – | – |
|
4
iShares Russell 2000 ETF
IWM
$67B
| $59.2M | 10.88% | 420,000 | – | – |
|
|
IMDX
5
Insight Molecular Diagnostics Inc. Common Stock
IMDX
$72.4M
| $15.9M | 2.92% | 3,056,680 | – | – |
|
|
MNK
6
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $14.4M | 2.66% | 322,411 | – | – |
|
|
AST
7
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
| $13.1M | 2.42% | 3,699,848 | – | – |
|
|
AST.WS
8
DELISTED
Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017)
AST.WS
| $164K | 0.03% | 328,205 | – | – |
|